Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Lancet Digit Health. 2019 Oct 17;1(7):e353–e362. doi: 10.1016/S2589-7500(19)30159-1

Table 2.

Cumulated number of cancers in different high and low risk subgroups at 6-, 12- and 24-months follow up visits after the S2 screening date

Number of individuals Cumulative number of cancers diagnosed at follow up visit
6 months 12 months 24 months 36 months
NLST training sample
Total screened 25097 274 358 464 574
High-risk subgroup Lung-RADS=4B 561 170 194 212 221
Lung-RADS= 4A/4B/4X 1333 227 274 308 327
ML>0.3 392 260 313 344 353
Low-risk subgroup Lung-RADS=1 or 2 23458 43 75 145 234
ML ≤ 0.1 24234 6 15 51 95
PanCan validation sample
Total screened 2294 43 54 72 92
High-risk subgroup Lung-RADS=4B 97 35 38 44 49
Lung-RADS=4A/4B/4X 235 41 48 58 65
VDT < 400 days 192 29 31 36 44
ML>0.3 221 41 51 61 65
Low-risk subgroup Lung-RADS=1 or 2 1698 1 3 9 20
ML ≤ 0.1 1266 0 0 2 10
VDT >600 days 2075 13 19 31 43